81 related articles for article (PubMed ID: 12894502)
1. Diverse responses between human pancreatic cancer cell lines to native alpha 1-antitrypsin and its C-terminal fragment.
Zelvyte I; Ohlsson B; Axelson J; Janciauskiene S
Anticancer Res; 2003; 23(3B):2267-73. PubMed ID: 12894502
[TBL] [Abstract][Full Text] [Related]
2. Dose-dependent biphasic induction and transcriptional activity of nuclear factor kappa B (NF-kappaB) in EA.hy.926 endothelial cells after low-dose X-irradiation.
Rödel F; Hantschel M; Hildebrandt G; Schultze-Mosgau S; Rödel C; Herrmann M; Sauer R; Voll RE
Int J Radiat Biol; 2004 Feb; 80(2):115-23. PubMed ID: 15164793
[TBL] [Abstract][Full Text] [Related]
3. Systemic and local immunosuppression in pancreatic cancer patients.
von Bernstorff W; Voss M; Freichel S; Schmid A; Vogel I; Jöhnk C; Henne-Bruns D; Kremer B; Kalthoff H
Clin Cancer Res; 2001 Mar; 7(3 Suppl):925s-932s. PubMed ID: 11300493
[TBL] [Abstract][Full Text] [Related]
4. alpha1-Antitrypsin regulates CD14 expression and soluble CD14 levels in human monocytes in vitro.
Nita IM; Serapinas D; Janciauskiene SM
Int J Biochem Cell Biol; 2007; 39(6):1165-76. PubMed ID: 17448722
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of the E3-ubiquitin ligase receptor subunit betaTRCP1 relates to constitutive nuclear factor-kappaB activation and chemoresistance in pancreatic carcinoma cells.
Müerköster S; Arlt A; Sipos B; Witt M; Grossmann M; Klöppel G; Kalthoff H; Fölsch UR; Schäfer H
Cancer Res; 2005 Feb; 65(4):1316-24. PubMed ID: 15735017
[TBL] [Abstract][Full Text] [Related]
6. Expression of transforming growth factor beta (TGF-beta1) in human epithelial alveolar cells: a pro-inflammatory mediator independent pathway.
Kwong KY; Literat A; Zhu NL; Huang HH; Li C; Jones CA; Minoo P
Life Sci; 2004 Apr; 74(24):2941-57. PubMed ID: 15051419
[TBL] [Abstract][Full Text] [Related]
7. Regulation of ovarian UT-OC-2 carcinoma cells by cytokines: effects on cell proliferation, activation of transcription factors and apoptosis.
Seppänen M; Lin L; Saarinen R; Punnonen R; Vihko KK
Acta Obstet Gynecol Scand; 2008; 87(9):902-9. PubMed ID: 18720042
[TBL] [Abstract][Full Text] [Related]
8. Cytokine gene expression and activation of NF-kappa B in aniline-induced splenic toxicity.
Wang J; Kannan S; Li H; Khan MF
Toxicol Appl Pharmacol; 2005 Feb; 203(1):36-44. PubMed ID: 15694462
[TBL] [Abstract][Full Text] [Related]
9. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
[TBL] [Abstract][Full Text] [Related]
10. Genetically induced pancreatic adenocarcinoma is highly immunogenic and causes spontaneous tumor-specific immune responses.
Garbe AI; Vermeer B; Gamrekelashvili J; von Wasielewski R; Greten FR; Westendorf AM; Buer J; Schmid RM; Manns MP; Korangy F; Greten TF
Cancer Res; 2006 Jan; 66(1):508-16. PubMed ID: 16397267
[TBL] [Abstract][Full Text] [Related]
11. Pentoxifylline inhibits endotoxin-induced NF-kappa B activation and associated production of proinflammatory cytokines.
Ji Q; Zhang L; Jia H; Xu J
Ann Clin Lab Sci; 2004; 34(4):427-36. PubMed ID: 15648785
[TBL] [Abstract][Full Text] [Related]
12. Tenascin C and annexin II expression in the process of pancreatic carcinogenesis.
Esposito I; Penzel R; Chaib-Harrireche M; Barcena U; Bergmann F; Riedl S; Kayed H; Giese N; Kleeff J; Friess H; Schirmacher P
J Pathol; 2006 Apr; 208(5):673-85. PubMed ID: 16450333
[TBL] [Abstract][Full Text] [Related]
13. Signal of proteinase-activated receptor-2 contributes to highly malignant potential of human pancreatic cancer by up-regulation of interleukin-8 release.
Ikeda O; Egami H; Ishiko T; Ishikawa S; Kamohara H; Hidaka H; Takahashi M; Ogawa M
Int J Oncol; 2006 Apr; 28(4):939-46. PubMed ID: 16525644
[TBL] [Abstract][Full Text] [Related]
14. Nuclear factor-kappaB contributes to hedgehog signaling pathway activation through sonic hedgehog induction in pancreatic cancer.
Nakashima H; Nakamura M; Yamaguchi H; Yamanaka N; Akiyoshi T; Koga K; Yamaguchi K; Tsuneyoshi M; Tanaka M; Katano M
Cancer Res; 2006 Jul; 66(14):7041-9. PubMed ID: 16849549
[TBL] [Abstract][Full Text] [Related]
15. The novel use of the human nasal epithelial cell line RPMI 2650 as an in vitro model to study the influence of allergens and cytokines on transforming growth factor-beta gene expression and protein release.
Salib RJ; Lau LC; Howarth PH
Clin Exp Allergy; 2005 Jun; 35(6):811-9. PubMed ID: 15969674
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-1alpha enhances IL-8 secretion through p38 mitogen-activated protein kinase and reactive oxygen species signaling in human pancreatic cancer cells.
Sawai H; Funahashi H; Okada Y; Matsuo Y; Sakamoto M; Yamamoto M; Takeyama H; Manabe T
Med Sci Monit; 2005 Oct; 11(10):BR343-50. PubMed ID: 16192891
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor beta 1(TGF-beta1) down-regulates TNFalpha-induced RANTES production in rheumatoid synovial fibroblasts through NF-kappaB-mediated transcriptional repression.
Cho ML; Min SY; Chang SH; Kim KW; Heo SB; Lee SH; Park SH; Cho CS; Kim HY
Immunol Lett; 2006 Jun; 105(2):159-66. PubMed ID: 16564576
[TBL] [Abstract][Full Text] [Related]
18. NF-kappa B involved in transcription enhancement of TGF-beta 1 induced by Ox-LDL in rat mesangial cells.
Lan Y; Zhou Q; Wu ZL
Chin Med J (Engl); 2004 Feb; 117(2):225-30. PubMed ID: 14975207
[TBL] [Abstract][Full Text] [Related]
19. Suppression of interleukin 6 and 8 production in head and neck cancer cells with curcumin via inhibition of Ikappa beta kinase.
Cohen AN; Veena MS; Srivatsan ES; Wang MB
Arch Otolaryngol Head Neck Surg; 2009 Feb; 135(2):190-7. PubMed ID: 19221248
[TBL] [Abstract][Full Text] [Related]
20. The induction of TGF-beta(1) and NF-kappaB parallels a biphasic time course of leukocyte/endothelial cell adhesion following low-dose X-irradiation.
Rödel F; Schaller U; Schultze-Mosgau S; Beuscher HU; Keilholz L; Herrmann M; Voll R; Sauer R; Hildebrandt G
Strahlenther Onkol; 2004 Apr; 180(4):194-200. PubMed ID: 15057429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
